Overall, when used appropriately with attention to nutrition and physical activity, semaglutide does not "ruin" metabolism but rather can improve multiple metabolic parameters while supporting clinically meaningful weight loss in appropriate patients
These findings provide evidence that the regulatory influence of endogenous GLP-1R signaling on bone resorption is likely mediated through pathways that involve calcitonin
You must be 18 or older with a BMI of 30 or higher, or a BMI of 27 or higher with at least one weight-related condition, such as type 2 diabetes, high blood pressure, high cholesterol, or sleep apnea
Active lifestyle: Patient exercises regularly and does not want to compromise muscle during a fat loss phase
Dushay J, Chui PC, Gopalakrishnan GS et al (2010) Increased fibroblast growth factor 21 in obesity and nonalcoholic fatty liver disease